Abstract
Rationale
It has been speculated that shared mechanisms underlie respiratory and cardiovascular diseases (CVD) including systemic inflammation or mutual risk factors. In this context, we sought to examine the associations of CVD-related plasma proteins with lung function as measured by spirometry in a large community-based cohort of adults.
Methods
The study included 5777 Framingham Heart Study participants who had spirometry and measurement of 71 CVD-related plasma proteins. The association of plasma proteins with lung function was assessed cross-sectionally and longitudinally using models accounting for familial correlations. Linear mixed models were used for the following measurements: FEV1%predicted, FVC%predicted, and FEV1/FVC ratio with secondary analyses examining obstructive and restrictive physiology at baseline and their new onset during follow up.
Measurements and main results
Among the 71 CVD-related plasma proteins, 13 proteins were associated in cross-sectional analyses with FEV1%predicted, 17 proteins were associated with FVC%predicted, and 1 protein was associated with FEV1/FVC. The proteins with the greatest inverse relations to FEV1%predicted and FVC%predicted included leptin, adrenomedullin, and plasminogen activator inhibitor-1; in contrast there were three proteins with positive relations to FEV1%predicted and FVC%predicted including insulin growth factor binding protein 2, tetranectin, and soluble receptor for advanced glycation end products. In longitudinal analyses, three proteins were associated with longitudinal change in FEV1 (ΔFEV1) and four with ΔFVC; no proteins were associated with ΔFEV1/FVC.
Conclusion
Our findings highlight CVD-related plasma proteins that are associated with lung function including markers of inflammation, adiposity, and fibrosis, representing proteins that may contribute both to respiratory and CVD risk.
Funder
national institutes of health
national heart, lung, and blood institute
Publisher
Public Library of Science (PLoS)
Reference43 articles.
1. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015;Mortality GBD, Causes of Death C;Lancet,2016
2. Mortality in the United States, 2017;SL Murphy;NCHS Data Brief,2018
3. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature;DD Sin;Chest,2005
4. Lung Function in Young Adults and Risk of Cardiovascular Events Over 29 Years: The CARDIA Study;MJ Cuttica;J Am Heart Assoc,2018
5. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity;J Finkelstein;Int J Chron Obstruct Pulmon Dis,2009